167 related articles for article (PubMed ID: 2933001)
1. [Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group].
Taguchi T; Sakai K; Terasawa T; Irie K; Okajima K; Yamamoto M; Kawahara T; Satomi T; Tomita K; Yamaguchi A
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2179-84. PubMed ID: 2933001
[TBL] [Abstract][Full Text] [Related]
2. [Phase II study of 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with malignant cancer--a multi-institutional cooperative study].
Niitani H; Kimura K; Saito T; Nakao I; Abe O; Urushizaki I; Ohta K; Yoshida Y; Kimura T; Kurihara M
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2044-51. PubMed ID: 2932059
[TBL] [Abstract][Full Text] [Related]
3. [Phase II study of 5'-DFUR in gastrointestinal and breast cancer].
Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2172-8. PubMed ID: 2933000
[TBL] [Abstract][Full Text] [Related]
4. [Clinical phase II study of 5'-DFUR for cancer of the digestive organs by a cooperative study group].
Urushizaki I; Kogo Y; Kouda K; Ishitani K; Niitsu Y; Matsuda M; Gocho Y; Koyama R; Nagai T; Saijo N
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2358-64. PubMed ID: 3000300
[TBL] [Abstract][Full Text] [Related]
5. [Clinical trial of 5'-deoxy-5-fluorouridine (5'-DFUR) in advanced cancer patients].
Irie K; Yasutake K; Imamura Y; Yoshimura Y; Yoshida M; Nakamura T; Suehiro I
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2371-8. PubMed ID: 2934026
[TBL] [Abstract][Full Text] [Related]
6. [Phase II study of 5'-DFUR (Furtulon) capsule for bladder cancer].
Kubota Y; Miura T; Shuin T; Kinoshita Y; Hosaka M; Kondo I; Moriyama M; Fukushima S; Fukuoka H; Miyai K
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2301-6. PubMed ID: 1834023
[TBL] [Abstract][Full Text] [Related]
7. [Clinical effect of 5'-deoxy-5-fluorouridine (5'-DFUR)].
Nakano Y; Ohota J; Fujita M; Taguchi T
Gan No Rinsho; 1985 May; 31(6 Suppl):746-50. PubMed ID: 3162050
[TBL] [Abstract][Full Text] [Related]
8. [Phase I study of 5'-deoxy-5-fluorouridine (5'-DFUR)].
Nakao I; Saito T; Kimura K; Wakui A; Yokoyama M; Kanamaru R; Furue H; Komita T; Ohta K; Murakami M
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2037-43. PubMed ID: 2932058
[TBL] [Abstract][Full Text] [Related]
9. [Co-operative clinical evaluation of 5'-DFUR tablets for breast cancer at 31 institutions].
Morimoto K; Taguchi T; Ohta J; Miura S; Ueda N; Yayoi K; Inaji H
Gan To Kagaku Ryoho; 1992 Jul; 19(7):1041-8. PubMed ID: 1385688
[TBL] [Abstract][Full Text] [Related]
10. [Phase II study of 5'-DFUR treatment of the bladder and prostatic cancer].
Ohmori H; Matsumura Y; Ochi J; Kobashi K; Akebi N; Saika T; Nanba K; Tanahashi T; Josen T; Nasu Y
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2307-14. PubMed ID: 1834024
[TBL] [Abstract][Full Text] [Related]
11. [Clinical trial of 5'-DFUR against various malignant tumors].
Okumura T
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2365-70. PubMed ID: 2934025
[TBL] [Abstract][Full Text] [Related]
12. [A new anticancer drug, 5'-deoxy-5-fluorouridine (5'-DFUR)].
Tsukagoshi S
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2977-82. PubMed ID: 2959207
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of oral administration of 5'-deoxy-5-fluorouridine (5'-DFUR) for solid tumors.
Shimizu E; Saijo N; Eguchi K; Shinkai T; Tominaga K; Sasaki Y; Fujita J; Nomori H; Hoshi A
Jpn J Clin Oncol; 1984 Dec; 14(4):679-83. PubMed ID: 6240546
[TBL] [Abstract][Full Text] [Related]
14. Phase II clinical evaluation of doxifluridine.
Hurteloup P; Armand JP; Cappelaere P; Metz R; Kerbrat P; Keiling R; Fumoleau P; Fargeot P; Schraub S; Bastit P
Cancer Treat Rep; 1986 Jun; 70(6):731-7. PubMed ID: 2942245
[TBL] [Abstract][Full Text] [Related]
15. [A comparative study of 5'-DFUR and tegafur in recurrent breast cancer].
Taguchi T; Terasawa T; Abe O; Yoshida Y; Tominaga T; Ogawa N
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2052-60. PubMed ID: 2932060
[TBL] [Abstract][Full Text] [Related]
16. [Phase II study of FF-705 by Clinical Cooperative Study Group].
Gan To Kagaku Ryoho; 1984 Jan; 11(1):150-6. PubMed ID: 6230055
[TBL] [Abstract][Full Text] [Related]
17. [Survival and changes of clinical laboratory data in phase II study with 5'-DFUR].
Taguchi T
Gan To Kagaku Ryoho; 1996 Jul; 23(8):1019-29. PubMed ID: 8687216
[TBL] [Abstract][Full Text] [Related]
18. [Clinical trial of 5'-deoxy-5-fluorouridine in malignant tumors under cooperative study (phase II study)].
Murakami M; Ota K; Yasue M; Hoshino A; Kamiya O; Kinoshita T; Yamada M; Hiraiwa K; Hachisuka K; Yamaguchi A
Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):1026-35. PubMed ID: 2944975
[No Abstract] [Full Text] [Related]
19. [Effects of 5'-deoxy-5-fluorouridine on human gastrointestinal and breast cancers xenografted to nude mice].
Fujita F; Fujita M; Taguchi T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1635-43. PubMed ID: 6236751
[TBL] [Abstract][Full Text] [Related]
20. [Clinical trial of 5'-DFUR in patients with recurrent breast cancer].
Morimoto T; Komaki K; Yamakawa T; Tanaka T; Konishi Y; Uomine Y; Miki H; Ooshimo K; Monden Y
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2983-9. PubMed ID: 2972258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
